Vooijs, W C <br/><br/>
B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.  [electronic resource] 

 -  British journal of cancer  1997 
 - 1163-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1997.528  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--chemistry<br/>B7-1 Antigen--immunology<br/>Clone Cells--drug effects<br/>Cytotoxicity Tests, Immunologic<br/>Hematopoietic Stem Cells--drug effects<br/>Hodgkin Disease--immunology<br/>Humans<br/>Immunohistochemistry<br/>Immunotherapy<br/>Leukocytes, Mononuclear--immunology<br/>Lymph Nodes--immunology<br/>Neutrophils--immunology<br/>Tissue Distribution<br/>Treatment Outcome<br/>Tumor Cells, Cultured